Related Experiment Video

Updated: Sep 20, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting

Valentina Sirri1, Marie Pierre Leibovitch, Serge Alexandre Leibovitch

  • 1Laboratoire de Génétique oncologique, CNRS UMR 8125, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France.

Oncogene
|August 29, 2003
PubMed

Insights

Ectopic expression of MRF4 induces growth arrest and differentiation in rhabdomyosarcoma cells. The MRF4 C-terminus acts as a key domain for transcriptional activity, offering insights into muscle gene regulation and tumor progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Rhabdomyosarcoma (RMS) exhibits uncontrolled proliferation and blocked differentiation despite key muscle regulatory gene expression.
  • Muscle regulatory factors (MRFs) like Myf-5, MyoD, and myogenin are crucial for muscle development but their roles in RMS are complex.

Purpose of the Study:

  • To investigate the role of MRF4 in inducing differentiation and growth arrest in RMS cells.
  • To identify the functional domains of MRF4 responsible for its activity in tumor cells.
  • To compare the regulatory mechanisms of MRF4 and MyoD in muscle gene expression.

Main Methods:

  • Ectopic expression of MRF4 in RD cells.
  • Deletion mapping to identify functional domains of MRF4.
  • Construction and analysis of chimeric MyoD/MRF4 proteins.
  • Comparative analysis of muscle-specific gene induction via MyoD activation with and without MRF4.

Main Results:

  • Ectopic MRF4 expression induced growth arrest and terminal differentiation in RD cells.
  • A C-terminal domain of MRF4 was identified as essential for its transcriptional activity.
  • This MRF4 C-terminal domain contains a conserved motif that can rescue MyoD activity in RD cells.
  • MRF4 and MyoD differentially regulate muscle gene expression, indicating distinct roles in differentiation.

Conclusions:

  • The C-terminus of MRF4 functions as both a specification and activation domain in cancer cells.
  • These findings provide a foundation for identifying genes involved in b-HLH-mediated differentiation versus tumor progression in RMS.
  • MRF4 represents a potential therapeutic target for promoting differentiation in rhabdomyosarcoma.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.